2,359 followers
A phase I open-label dose-escalation study of the anti-HER3 monoclonal https://t.co/Tr0Wf32Mve #hvhebron #onco [Text complet] @BMC_series
A phase I open-label dose-escalation study of the anti-HER3 monoclonal https://t.co/Tr0Wf32Mve #hvhebron #onco [Text complet] @BMC_series